Efficacy of Epoetin Beta on Hemoglobin, Quality of Life, and Transfusion Needs in Patients with Anemia Due to Hormone-refractory Prostate Cancer - A Randomized Study

Author： Johansson J-E.   Wersäll P.   Brandberg Y.   Andersson S-O.   Nordström L.  

Publisher： Informa Healthcare

ISSN： 0036-5599

Source： Scandinavian Journal of Urology and Nephrology, Vol.35, Iss.4, 2001-09, pp. : 288-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Open-label phase II study of ZD0473 in patients with metastatic hormone-refractory prostate cancer

By Tyrrell C.   Bullard S.   Barber J.   Graham J.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 158-158

Elsevier

Access to resources Recommend Favorite

The Role of Endothelin in Hormone-Refractory Prostate Cancer

By Zonnenberg B.A.   Voest E.E.  

European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. : 9-14

Elsevier

Access to resources Recommend Favorite

Revolutions in the Management of Hormone-Refractory Prostate Cancer

By Abrahamsson P.-A.  

European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

The Role of Urologists in the Management of Hormone-Refractory Prostate Cancer

By Pummer K.  

European Urology Supplements, Vol. 1, Iss. 2, 2002-05 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

Endothelin and Skeletal Metastases in Hormone-Refractory Prostate Cancer

By Hamdy F.C.  

European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite